CCL5 and liver disorder: In CHB patients, serum CCL5 levels are markedly elevated in those with moderate to severe liver disease compared to mild cases, indicating that viral infection activates innate and adaptive immune systems early on, triggering CCL5 production from T lymphocytes, macrophages, platelets, and other immune cells (16, 17).